7/103 sources · 3 publishersUpdated Nov 13, 00:47 UTC
Vir Biotechnology prices $150 million public stock offering
+1 new source since this summary was written
Vir Biotechnology announced that it priced a public offering of 15.0 million shares at $10.00 each, raising $150.0 million. The underwriters received a 30‑day option to purchase additional shares, amounting to up to 15% of the offering. Closing of the transaction is expected on November 16, 2026, subject to customary conditions.
Why it matters
The company will receive approximately $150 million in gross proceeds, which can be used to fund its infectious‑disease and oncology programs. Existing shareholders may experience dilution from the new shares and the underwriters' option.
Key facts
- 1The offering was priced at $10.00 per share. tradingview.com
- 2Vir issued 15.0 million shares in the offering. tradingview.com
- 3The gross proceeds of the offering are $150.0 million. tradingview.com
- 4Underwriters have a 30‑day option to purchase an additional 2.3 million shares. tradingview.com
- 5The underwriters' option represents up to 15% of the shares offered. investing.com
- 6Closing of the offering is expected on November 16, 2026, subject to conditions. tradingview.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.